Global coagulation assays in patients with diabetes mellitus
Abstract Background There is significant heterogeneity in the incidence and severity of diabetes‐associated vascular complications and there is no routine biomarker that accurately predicts these outcomes. This pilot study investigates the role of global coagulation assays in patients with diabetes...
Guardado en:
Autores principales: | Hui Yin Lim, Brandon Lui, Mark Tacey, Anna Kwok, Suresh Varadarajan, Geoffrey Donnan, Harshal Nandurkar, Prahlad Ho |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2e7f05368ce845b79d5f884aa6003c95 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Monitoring coagulation-fibrinolysis activation prompted timely diagnosis of hemophagocytic lymphohistiocytosis-related disseminated intravascular coagulation
por: Liqin Ling, et al.
Publicado: (2021) -
Assessing plasminogen activation potential with global fibrinolytic assays
por: Tetsumei Urano, et al.
Publicado: (2020) -
Development and application of global assays of hyper‐ and hypofibrinolysis
por: Anton Ilich, et al.
Publicado: (2020) -
Microfluidic hemophilia models using blood from healthy donors
por: Xinren Yu, et al.
Publicado: (2020) -
Complications and management of coagulation disorders in leukemia patients
por: Lad DP, et al.
Publicado: (2017)